2012
DOI: 10.1007/s12603-011-0155-9
|View full text |Cite
|
Sign up to set email alerts
|

Screening for frailty in elderly emergency department patients by using the Identification of Seniors At Risk (ISAR)

Abstract: ISAR is a useful screening tool for frailty and identifies elderly patients at risk of adverse outcomes after an ED visit. ISAR can also be used to select high-risk patients more likely to benefit from a geriatric approach or intervention, independently of admission or discharge.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
80
0
2

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 104 publications
(96 citation statements)
references
References 35 publications
5
80
0
2
Order By: Relevance
“…Our finding, that the ISAR has a poor discriminating value to predict adverse outcomes in older patients discharged from UK acute medical units, shows that the ISAR did not perform as well as in the original Canadian study [6], where the tool was shown to be 'fair' discriminating value (AUC: 0.71). However, our findings are compatible with more recent European and Asian studies [7][8][9][10][11][12] which have reported areas under the curves for the ISAR between 'no value' (0.5) and 'fair' (0.7). As our study only evaluated the 'best' 40%, further studies are warranted taking 'all comers' before the utility of this tool can be judged.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Our finding, that the ISAR has a poor discriminating value to predict adverse outcomes in older patients discharged from UK acute medical units, shows that the ISAR did not perform as well as in the original Canadian study [6], where the tool was shown to be 'fair' discriminating value (AUC: 0.71). However, our findings are compatible with more recent European and Asian studies [7][8][9][10][11][12] which have reported areas under the curves for the ISAR between 'no value' (0.5) and 'fair' (0.7). As our study only evaluated the 'best' 40%, further studies are warranted taking 'all comers' before the utility of this tool can be judged.…”
Section: Discussionsupporting
confidence: 93%
“…The ISAR includes six simple dichotomous questions, making it simple and acceptable for patients and staff alike. The ISAR has been tested in North America [6], many European countries [7][8][9][10][11] and Hong Kong [12] where its predictive value varied between 'fair' and 'poor' [determined using receiveroperator curve (ROC) analysis which takes both specificity and sensitivity into account], the difference depending upon the case mix and the health services available in different countries. For the ISAR to be used in the UK, it is important to demonstrate adequate predictive ability in UK settings, but this has not yet been done, and this was the purpose of this study.…”
Section: Introductionmentioning
confidence: 99%
“…In a recent study the ISAR identified frail patients in the emergency departments with an increased vulnerability to internal and external stressors [15]. …”
Section: Discussionmentioning
confidence: 99%
“…Several studies reported composite outcomes of various combinations of undesired outcomes as "any adverse outcome." 66,67,70,76,77,79 The ISAR studies assessed the instrument's prognostic accuracy for ED return visits at 30 to 180 days, functional decline at 30 to 90 days, and hospital readmission at 30 to 180 days. In addition, multiple studies reported composite outcomes of "any adverse outcome" at 30 to 180 days, although the components of the combined endpoint varied from study to study.…”
Section: Screening Instrumentsmentioning
confidence: 99%